Enveda Bioscience

Enveda

This biotechnology company develops pharmaceutical drug candidates for patients with inflammatory and metabolic diseases using an artificial intelligence platform to decode plant chemistry.

Enveda Biosciences

This deep-tech company develops nature-derived drug candidates for pharmaceutical researchers and clinicians using a chemical discovery platform.

Pragma Bio

This company develops a machine learning platform to discover and manufacture microbiome-derived small molecule medicines for patients with immunological disorders and cancer.

Avicenna Biosciences

The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.

PharmEnable

This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.

Pragma Biosciences

This company develops a drug discovery platform using machine learning to identify microbiome-derived small molecules for pharmaceutical and healthcare partners.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Deepcure

This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.